Realta Life Sciencesincis A Clinical Stage Biopharmaceutical Company Based In Norfolkvirginiawith Operations In Aguadillapuerto Ricofounded In 2018The Company Focuses On Developing Therapies For Rare And Acute Inflammatory Diseases Using Its Proprietary Epiccengineered Peptides For Innate Immune Complement And Cellsplatformthis Innovative Platform Utilizes Insights From The Human Astrovirus Hastv 1 To Create Engineered Peptides That Target Complement Pathways And Suppress Neutrophil Mediated Inflammation Realta S Clinical Pipeline Includes Rls 0071Pegtarazimod Which Has Received Orphan Drug And Fast Track Designations From The Fda For Treating Hypoxic Ischemic Encephalopathy In Newbornsthe Company Is Also Advancing This Candidate Through Phase 2 Trials For Acute Exacerbations Of Copd And Acute Graft Versus Host Diseaseadditionallyrealta Is Developing Therapies For Platelet Refractoriness In Cancer Patientsthe Company Holds Active Patents In Multiple Jurisdictions And Is Led By Ceo David Mareksupported By A Dedicated Team
No conferences found for this company.
| Company Name | Realta Life Sciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
